Welcome to our dedicated page for Waystar Holding SEC filings (Ticker: WAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthcare payment platforms like Waystar generate disclosures packed with reimbursement rules, payer-mix tables, and subscription revenue details—information investors need yet struggle to find quickly. If you have ever searched for Waystar insider trading Form 4 transactions or wondered how to decode the company’s deferred revenue footnotes, you know the challenge.
Stock Titan solves this problem by pairing real-time EDGAR feeds with AI that turns complex jargon into clear insights. From a single dashboard you can:
- Track Waystar Form 4 insider transactions real-time and spot buying or selling before material events.
- Dive into each Waystar quarterly earnings report 10-Q filing with concise AI annotations on churn, average revenue per client, and regulatory exposure.
- Skim an AI-generated brief of the Waystar annual report 10-K simplified to understand revenue-cycle market share, cloud migration costs, and cybersecurity risks.
- Receive alerts when a Waystar 8-K material events explained post details new payer contracts or leadership changes.
Still asking, “How do I read Waystar’s proxy statement executive compensation?” or “Can I get a Waystar earnings report filing analysis without sifting through 200 pages?” Our platform answers both by extracting equity-based pay data and key performance metrics into digestible summaries. Whether you are monitoring Waystar executive stock transactions Form 4, comparing subscription growth across quarters, or simply understanding Waystar SEC documents with AI, Stock Titan equips you to make informed decisions faster.
Matthew J. Hawkins, Chief Executive Officer and Director of Waystar Holding Corp. (WAY), reported multiple insider transactions. On 06/06/2025 he had 46,657 shares disposed at an average price of $40.55, resulting in reported beneficial ownership of 717,474 shares (which includes unvested RSUs). Subsequent automatic transactions under a plan intended to satisfy Rule 10b5-1 conditions show acquisitions of 12,200 and 12,800 shares on 09/22/2025 and 09/23/2025 at a $4.14 option price (with related sales at weighted average prices of about $38.08). The filing discloses holdings of exercisable stock options with a $4.14 exercise price and additional equity held indirectly through two grantor retained annuity trusts totaling 593,135 options reported indirectly.
Waystar Holding Corp. insider transactions by Chief Business Officer Eric L. Sinclair III. The reporting person acquired 9,701 shares by exercising options at an exercise price of $4.14 and immediately acquired an equal number of underlying shares. The report also shows sale of 9,701 shares of common stock at a weighted-average price of $37.6343, executed across multiple transactions in a price range of $37.24 to $38.14. Following these transactions the reporting person beneficially owned 484,527 shares before the sale and 474,826 shares after. Some holdings include unvested RSUs and the option grants are currently vested. The acquisitions occurred pursuant to an internal plan intended to satisfy Rule 10b5-1(c) conditions.
Form 144 filed for Waystar Holding Corp. (WAY) discloses a proposed sale of 50,000 common shares to be effected on 09/22/2025 through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $1,890,000.00. The shares were acquired on 09/22/2025 by exercise of stock options and paid for in cash. The filing also reports two prior 10b5-1 sales by the same account: 46,667 shares on 07/15/2025 for $1,785,540.12 and 46,667 shares on 08/12/2025 for $1,617,577.89. The 50,000-share notice represents approximately 0.0287% of the issuer's reported 174,238,972 outstanding shares. The filer certifies there is no undisclosed material adverse information and references Rule 10b5-1 planning where applicable.
Waystar Holding Corp. insider transactions reported on Form 4: Paul G. Moskowitz, a Bain Capital partner and Waystar director/10% owner, disclosed disposals of common stock tied to a registered public offering on 09/12/2025. The report shows 4,295,139 shares sold at $39.21 and 516,371 shares transferred in distributions, leaving the Bain Capital entities with 13,243,539 shares beneficially owned after the transactions. Some distributed shares are subject to lock-up restrictions until November 11, 2025, except as permitted by J.P. Morgan Securities.
Bain Capital entities disclosed sales and distributions of Waystar Holding Corp. (WAY) common stock on 09/12/2025. The filing reports 4,295,139 shares disposed in a registered public offering at $39.21 per share and an additional 516,371 shares distributed to members/partners. The filing states Derby Investor sold 298,303 shares and Derby SPV Investor sold 3,996,836 in the offering. After the reported transactions the filing shows beneficial ownership figures of 13,759,910 and 13,243,539 shares for the reporting entities on an indirect basis. Certain distributed shares (397,013 from Derby Investor and 119,358 from Derby SPV Investor) are subject to lock-up restrictions generally until 11/11/2025. The Form 4 is signed by Bain Capital's authorized signatory on 09/16/2025.
Derby LuxCo S.a r.l. and EQT Fund Management S.a r.l. reported a transaction in Waystar Holding Corp. (WAY). On 09/12/2025 the reporting persons sold 7,766,088 shares of Waystar common stock in a secondary offering at $39.21 per share. After the sale, the reporting persons beneficially own 24,879,437 shares, held indirectly by Derby LuxCo. The filing states that EQT VIII owns 100% of Derby LuxCo and that EQT Fund Management S.a r.l. has exclusive management responsibility for the investment vehicles comprising the majority of EQT VIII commitments. The form is signed by authorized managers and dated 09/16/2025.
Canada Pension Plan Investment Board (CPPIB) reported the sale of 5,938,773 shares of Waystar Holding Corp. (WAY) at $39.21 per share in a secondary offering that closed on 09/12/2025. The shares sold were held directly by CPP Investment Board Private Holdings (4) Inc., a wholly owned subsidiary of CPPIB, and CPPIB is an indirect beneficial owner of the remaining shares.
After the reported disposition, the filing shows 19,025,452 shares beneficially owned indirectly by CPPIB/Holdings (4). The Form 4 was signed by Pierre Abinakle on behalf of both reporting entities.
Waystar Holding Corp. entered into an underwriting agreement with J.P. Morgan Securities LLC to facilitate an underwritten offering of 18,000,000 shares of the company's common stock by the selling stockholders under its Form S-3 registration statement. The company did not sell any shares and will not receive any proceeds from the transaction. The offering is expected to close on September 12, 2025, subject to customary closing conditions.
Waystar Holding Corp. is registering for the resale of 18,000,000 shares of common stock by selling stockholders; Waystar will not receive proceeds.
The shares represent part of holdings by institutional investors including EQT, CPPIB, and Bain. Waystar had 174,146,070 shares outstanding as of June 30, 2025, and the prospectus notes outstanding options, RSUs, plan pools, and shares to be issued in connection with the announced acquisition of Iodine. The selling stockholders will receive net proceeds and bear underwriting discounts; J.P. Morgan is sole underwriter and expects delivery about September 12, 2025. The filing repeats the company mission, platform scale (over 30,000 clients, >1 million providers, >6 billion transactions and ~$1.8 trillion gross claims volume in 2024), concentration metrics (top 10 clients ~11.2% of 2024 revenue), lock-up and registration mechanics, and extensive risk factors including concentrated institutional ownership, internal control requirements, market volatility, and dividend policy (no current dividend).